Mostrar el registro sencillo del ítem

dc.contributor.authorOttaviani, Silvia
dc.contributor.authorStebbing, Justin
dc.contributor.authorFrampton, Adam E
dc.contributor.authorZagorac, Sladjana
dc.contributor.authorKrell, Jonathan
dc.contributor.authorde Giorgio, Alexander
dc.contributor.authorTrabulo, Sara M
dc.contributor.authorNguyen, Van T M
dc.contributor.authorMagnani, Luca
dc.contributor.authorFeng, Hugang
dc.contributor.authorGiovannetti, Elisa
dc.contributor.authorFunel, Niccola
dc.contributor.authorGress, Thomas M
dc.contributor.authorJiao, Long R
dc.contributor.authorLombardo, Ylenia
dc.contributor.authorLemoine, Nicholas R
dc.contributor.authorHeeschen, Christopher 
dc.contributor.authorCastellano, Leandro
dc.date.accessioned2018-09-24T11:15:11Z
dc.date.available2018-09-24T11:15:11Z
dc.date.issued2018-05-10
dc.identifier.citationNat Commun. 2018; 9(1): 1845.es_ES
dc.identifier.issn2041-1723es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/6449
dc.description.abstractTGF-β/Activin induces epithelial-to-mesenchymal transition and stemness in pancreatic ductal adenocarcinoma (PDAC). However, the microRNAs (miRNAs) regulated during this response have remained yet undetermined. Here, we show that TGF-β transcriptionally induces MIR100HG lncRNA, containing miR-100, miR-125b and let-7a in its intron, via SMAD2/3. Interestingly, we find that although the pro-tumourigenic miR-100 and miR-125b accordingly increase, the amount of anti-tumourigenic let-7a is unchanged, as TGF-β also induces LIN28B inhibiting its maturation. Notably, we demonstrate that inactivation of miR-125b or miR-100 affects the TGF-β-mediated response indicating that these miRNAs are important TGF-β effectors. We integrate AGO2-RIP-seq with RNA-seq to identify the global regulation exerted by these miRNAs in PDAC cells. Transcripts targeted by miR-125b and miR-100 significantly overlap and mainly inhibit p53 and cell-cell junctions' pathways. Together, we uncover that TGF-β induces an lncRNA, whose encoded miRNAs, miR-100, let-7a and miR-125b play opposing roles in controlling PDAC tumourigenesis.es_ES
dc.description.sponsorshipThe authors thank Action Against Cancer (AAC), Pancreatic Cancer UK (PCUK), The Academy of Medical Sciences, The Royal College of Surgeons of Edinburgh, The Colin McDavid Family Trust, No Surrender Cancer Trust (in memory of Jason Boas), Mr Alessandro Dusi, Cheryl Whitehead, BHM, Sir Douglas Myers, and The Ralph Bates Pancreatic Cancer Research Fund for funding this study. Financial support was provided by the Dutch Cancer Society, KWF# 10401 grant to E.G., Italian Association for Cancer Research AIRC/Start-Up grant to E.G., Istituto Toscano Tumouri ITT-grant to N.F. and E.G., and the Regione Toscana "Progetto DIAMANTE"/FAS grant to N.F. and E.G. The authors thank Prof. Matthias Lohr and Dr Rainer Heuchel at Karolinska University Hospital, Stockholm, Sweden, for providing the TGF-beta 1 and empty vector expressing PANC-1 cells. This work used the computing resources of the UK MEDical BIOinformatics partnership-aggregation, integration, visualization, and analysis of large, complex data (UK MED-BIO) which is supported by the Medical Research Council [grant number MR/L01632X/1].es_ES
dc.language.isoenges_ES
dc.publisherNature Publishing Group es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.subjectCANCER STEM-CELLSes_ES
dc.subjectPANCREATIC TUMOR-GROWTHes_ES
dc.subjectMESENCHYMAL TRANSITIONes_ES
dc.subjectLASER MICRODISSECTIONes_ES
dc.subjectSELF-RENEWALes_ES
dc.subjectEXPRESSIONes_ES
dc.subjectMICRORNASes_ES
dc.subjectTARGETes_ES
dc.subjectADENOCARCINOMAes_ES
dc.subjectBIOGENESISes_ES
dc.titleTGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progressiones_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución-NoComercial-CompartirIgual 4.0 Internacional*
dc.identifier.pubmedID29748571es_ES
dc.format.volume9es_ES
dc.format.number1es_ES
dc.format.page1845es_ES
dc.identifier.doi10.1038/s41467-018-03962-xes_ES
dc.contributor.funderAction Against Cancer 
dc.contributor.funderPancreatic Cancer UK 
dc.contributor.funderAcademy of Medical Sciences (Reino Unido) 
dc.contributor.funderRoyal College of Surgeons of Edinburgh 
dc.contributor.funderColin McDavid Family Trust 
dc.contributor.funderNo Surrender Cancer Trust
dc.contributor.funderRalph Bates Pancreatic Cancer Research Fund
dc.contributor.funderDutch Cancer Society (Holanda) 
dc.contributor.funderItalian Association for Cancer Research 
dc.contributor.funderTumour Institute of Tuscany (Italia) 
dc.contributor.funderRegione Toscana "Progetto DIAMANTE"/FAS grant
dc.contributor.funderMedical Research Council (Reino Unido) 
dc.description.peerreviewed
dc.identifier.e-issn2041-1723es_ES
dc.relation.publisherversionhttps://doi.org/10.1038/s41467-018-03962-Xes_ES
dc.identifier.journalNature communicationses_ES
dc.repisalud.institucionCNIOes_ES
dc.repisalud.orgCNIOCNIO::Grupos de investigaciónes_ES
dc.repisalud.orgCNIOCNIO::Grupos de investigación::Grupo de Biología Computacional Estructurales_ES
dc.rights.accessRightsopen accesses_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail
Acceso Abierto
Thumbnail
Acceso Abierto
Thumbnail
Acceso Abierto
Thumbnail
Acceso Abierto
Acceso Abierto
Acceso Abierto
Acceso Abierto
Acceso Abierto
Acceso Abierto
Acceso Abierto
Acceso Abierto
Acceso Abierto
Acceso Abierto
Acceso Abierto
Acceso Abierto

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial-CompartirIgual 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Atribución-NoComercial-CompartirIgual 4.0 Internacional